Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
25
COYA Quote, Financials, Valuation and Earnings
Last price:
$5.46
Seasonality move
:
29.02%
Day range:
$5.29 - $5.75
52-week range:
$4.65 - $8.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
22.94x
P/B ratio:
4.19x
Volume:
89K
Avg. volume:
200.2K
1-year change:
--
Market cap:
$114.5M
Revenue:
$3.6M
EPS (TTM):
-$1.10
Earnings Data
Next earnings date for COYA
Mar 12
2026
Most recent earnings per share
-$0.13
Beat by $0.18
(Nov 12/2025)
Consensus Estimate
-$0.30
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
COYA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/12/2026 | Q4 | $1.9M | -- | -- | -$0.30 | -- |
| 11/12/2025 | Q3 | $3.7M | $3.6M | -$0.13 | -$0.30 | $0.18 |
| 08/12/2025 | Q2 | $668.6K | $163.6K | -$0.36 | -$0.43 | $0.07 |
| 05/13/2025 | Q1 | $2M | $257.9K | -$0.44 | -$0.13 | -$0.31 |
| 03/18/2025 | Q4 | $80K | $2K | -$0.17 | -$0.14 | -$0.03 |
| 11/06/2024 | Q3 | $175K | -- | -$0.26 | -- | -- |
| 08/12/2024 | Q2 | $3.9M | $3.4M | -$0.19 | -- | -- |
| 05/09/2024 | Q1 | -- | $126.8K | -$0.35 | -- | -- |
| 03/19/2024 | Q4 | $7.5M | $6M | $0.15 | -- | -- |
| 11/08/2023 | Q3 | -- | -- | -$0.34 | -- | -- |
| 08/08/2023 | Q2 | -- | -- | -$0.31 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.28 | -- | -- |
| 03/29/2023 | Q4 | -- | -- | -$0.32 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.42 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.52 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.26 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.25 | -- | -- |
Coya Therapeutics, Inc. Earnings Questions
-
How Much did Coya Therapeutics, Inc. Generate in Revenue Last Quarter?
Coya Therapeutics, Inc. reported $3.6M worth of top line sales in its most recent quarter.
-
Did Coya Therapeutics, Inc. Beat Earnings Last Quarter?
Coya Therapeutics, Inc. announced earnings per share of -$0.13 which represents a beat of analyst forecast a -$0.30 per share.
-
Is Coya Therapeutics, Inc. Profitable?
Coya Therapeutics, Inc. reported $3.6M that represents $0.21 per share over the last quarter.
-
What is the Analyst Consensus for Coya Therapeutics, Inc. EPS Next Year?
Coya Therapeutics, Inc.'s earnings are forecast to decrease from -$0.98 per share to -$1.22 per share next year representing a decrease of -24.94%.
-
When is Coya Therapeutics, Inc.'s Earnings Date?
Coya Therapeutics, Inc.'s next earnings date is March 12, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
